Momentum for COVID-19 Signal Surges After Strategic Partnership With Sherlock Biosciences
It's only May the 4th and it's already been a busy month for our team! The hard work on the development of our COVID-19 Signal is starting to attract the attention of the outside world and is gaining a major head of steam.
First, we announced a strategic partnership with The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic, to enable LogicInk to use Sherlock's CRISPR technology.
This is hugely important because the partnership will allow us to combine our technologies to develop a rapid, instrument-free test that can be used at home and in point-of-care settings like doctor’s offices, pharmacies and mobile clinics.
But wait, that's not all!
We're also pleased to share that LogicInk's COVID-19 Signal was recognized by Fast Company as an honorable mention in its World Changing Ideas 2021 awards. This is the second time we've been recognized in the awards' five year history.
Exciting times! More good news to share soon...